- Home
- NVO vs HSBC Comparison
NVO vs HSBC Comparison
Compare NVO & HSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVO
- HSBC
- Stock Information
- Founded
- NVO 1923
- HSBC 1865
- Country
- NVO Denmark
- HSBC United Kingdom
- Employees
- NVO N/A
- HSBC N/A
- Industry
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- HSBC Savings Institutions
- Sector
- NVO Health Care
- HSBC Finance
- Exchange
- NVO Nasdaq
- HSBC Nasdaq
- Market Cap
- NVO 243.4B
- HSBC 226.5B
- IPO Year
- NVO N/A
- HSBC N/A
- Fundamental
- Price
- NVO $48.46
- HSBC $70.92
- Analyst Decision
- NVO Buy
- HSBC Buy
- Analyst Count
- NVO 10
- HSBC 2
- Target Price
- NVO $80.40
- HSBC N/A
- AVG Volume (30 Days)
- NVO 13.5M
- HSBC 1.9M
- Earning Date
- NVO 11-05-2025
- HSBC 10-28-2025
- Dividend Yield
- NVO 2.54%
- HSBC 4.63%
- EPS Growth
- NVO 10.06
- HSBC N/A
- EPS
- NVO 3.67
- HSBC 0.93
- Revenue
- NVO $49,580,393,058.00
- HSBC $57,976,000,000.00
- Revenue This Year
- NVO $9.21
- HSBC $12.31
- Revenue Next Year
- NVO $5.64
- HSBC $1.85
- P/E Ratio
- NVO $13.22
- HSBC $76.30
- Revenue Growth
- NVO 16.64
- HSBC 0.01
- 52 Week Low
- NVO $45.05
- HSBC $44.40
- 52 Week High
- NVO $112.52
- HSBC $72.21
- Technical
- Relative Strength Index (RSI)
- NVO 26.48
- HSBC 63.25
- Support Level
- NVO $48.49
- HSBC $69.46
- Resistance Level
- NVO $49.90
- HSBC $70.48
- Average True Range (ATR)
- NVO 1.21
- HSBC 0.82
- MACD
- NVO -0.58
- HSBC 0.36
- Stochastic Oscillator
- NVO 22.84
- HSBC 94.01
About NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About HSBC HSBC Holdings plc.
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and 40 million customers worldwide. It operates in more than 50 countries with more than 200,000 full-time staff. The United Kingdom and Hong Kong are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.